The devastating impact of opioid abuse and dependence on the individual, family, and society are well known but extremely difficult to combat. During pregnancy, opioid drugs and withdrawal also affect fetal brain development and newborn neural functions, in addition to maternal effects. Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome (NAS/NOWS) rates have drastically increased in the US in the past decade. Solutions to this complex problem must be multi-faceted, which would be greatly enhanced by a translational, multidisciplinary understanding. Therefore, this mini-review incorporates biomedical, clinical, and policy aspects of opioid use during pregnancy. We review the known roles for endogenous opioids in mediating circuit formation and function in the developing brain, discuss how exogenous opioid drug use and addiction impact these processes in animal models and humans, and discuss the implications of these data on public policy. We suggest that some current policy initiatives produce unintended harm on both mothers and their children and delineate recommendations for how legislation could better contribute to addiction recovery and increase neural resilience in affected children.
Impact statement
Opioid abuse is a critical epidemic affecting individuals, families, and communities. This mini-review summarizes current literature on the impact of opioid drugs—including prescription pain relievers and illicit opioids—on neurobiological and neurobehavioral development. Using concepts related to the medical model of addiction as a brain disease, we review the public policy implications of these data and identify needs for future investigations.
VolkowNDKoroshetzWJ.The role of neurologists in tackling the opioid epidemic. Nat Rev Neurol2019;
15:301–5
2.
LeenJLSJuurlinkDN.Carfentanil: a narrative review of its pharmacology and public health concerns. Can J Anesth/J Can Anesth2019;
66:414–21
3.
Quality CfBHSa. 2013 National Survey on Drug Use and Health.
Rockville, MD:
Services SAaMH, Administration, 2014
4.
HoneinMABoyleCRedfieldRR.Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics2019;
143:e20183801
5.
HolbrookAKaltenbachK.Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse2012;
38:575–9
6.
JonesHEHeilSHO'GradyKEMartinPRKaltenbachKCoyleMGStineSMSelbyPArriaAMFischerG.Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abuse2009;
35:375–80
7.
TongYChabotJGShenSHO'DowdBFGeorgeSRQuirionR.Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization study. J Chem Neuroanatomy2000;
18:209–22
8.
BargJLevyRSimantovR.Expression of the three opioid receptor subtypes mu, Delta and kappa in guinea pig and rat brain cell cultures and in vivo. Int J Dev Neurosci1989;
7:173–9
9.
RiusRABargJBemWTCosciaCJLohYP.The prenatal development profile of expression of opioid peptides and receptors in the mouse brain. Brain Res Dev Brain Res1991;
58:237–41
10.
Matus-LeibovitchNEzra-MacabeeVSayaDAttaliBAvidor-ReissTBargJVogelZ.Increased expression of synapsin I mRNA in defined areas of the rat Central nervous system following chronic morphine treatment. Brain Res Mol Brain Res1995;
34:221–30
11.
SteingartRABargJMaslatonJNesherMYanaiJ.Pre- and postsynaptic alterations in the septohippocampal cholinergic innervations after prenatal exposure to drugs. Brain Res Bull1998;
46:203–9
12.
VaturyOBargJSlotkinTAYanaiJ.Altered localization of choline transporter sites in the mouse hippocampus after prenatal heroin exposure. Brain Res Bull2004;
63:25–32
13.
DiNieriJAWangXSzutoriszHSpanoSMKaurJCasacciaPDow-EdwardsDHurdYL.Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry2011;
70:763–9
14.
SpanoMSEllgrenMWangXHurdYL.Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiatry2007;
61:554–63
15.
WangXDow-EdwardsDAndersonVMinkoffHHurdYL.Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J2006;
6:255–64
16.
WangHCuzonVCPickelVM.Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation. Neuroscience2003;
118:695–708
17.
KibalyCXuCCahillCMEvansCJLawPY.Non-nociceptive roles of opioids in the CNS: opioids' effects on neurogenesis, learning, memory and affect. Nat Rev Neurosci2019;
20:5–18
18.
RossEJGrahamDLMoneyKMStanwoodGD.Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology2015;
40:61–87
19.
FokinaVMPatrikeevaSLZharikovaOLNanovskayaTNHankinsGVAhmedMS.Transplacental transfer and metabolism of buprenorphine in preterm human placenta. Am J Perinatol2011;
28:25–32
20.
GerdinERaneALindbergB.Transplacental transfer of morphine in man. J Perinatal Med1990;
18:305–12
21.
NanovskayaTNNekhayevaIAHankinsGDAhmedMS.Transfer of methadone across the dually perfused preterm human placental lobule. Am J Obstet Gynecol2008;
198:126.e1–4
22.
MatthewsSMcGowanP.Developmental programming of the HPA axis and related behaviours: epigenetic mechanisms. J Endocrinol2019;
242:T69--T79
23.
BruntonPJ.Endogenous opioid signalling in the brain during pregnancy and lactation. Cell Tissue Res2019;
375:69–83
24.
JasarevicEHowardCDMorrisonKMisicAWeinkopffTScottPHunterCBeitingDBaleTL.The maternal vaginal microbiome partially mediates the effects of prenatal stress on offspring gut and hypothalamus. Nat Neurosci2018;
21:1061–71
25.
McLaughlinPJTobiasSWLangCMZagonIS.Opioid receptor blockade during prenatal life modifies postnatal behavioral development. Pharmacol Biochem Behav1997;
58:1075–82
26.
McLaughlinPJWylieJDBloomGGriffithJWZagonIS.Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: maternal and preweaning effects. Pharmacol Biochem Behav2002;
71:171–81
LuRLiuXLongHMaL.Effects of prenatal cocaine and heroin exposure on neuronal dendrite morphogenesis and spatial recognition memory in mice. Neurosci Lett2012;
522:128–33
29.
SchrottLMFranklinLSerranoPA.Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training. Brain Res2008;
1198:132–40
30.
WangYHanTZ.Prenatal exposure to heroin in mice elicits memory deficits that can be attributed to neuronal apoptosis. Neuroscience2009;
160:330–8
31.
SithisarnTLeganSJWestgatePMWilsonMWellmannKBadaHSBarronS.The effects of perinatal oxycodone exposure on behavioral outcome in a rodent model. Front Pediatr2017;
5:180
32.
ChiangYCHungTWHoIK.Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine. Addict Biol2014;
19:676–86
33.
RamseyNFNiesinkRJVan ReeJM.Prenatal exposure to morphine enhances cocaine and heroin self-administration in drug-naive rats. Drug Alcohol Depend1993;
33:41–51
VillarrealDMDerrickBVathyI.Prenatal morphine exposure attenuates the maintenance of late LTP in lateral perforant path projections to the dentate gyrus and the CA3 region in vivo. J Neurophysiol2008;
99:1235–42
36.
WuPLYangYNSuenJLYangYSHYangCHYangSN.Long-Lasting alterations in gene expression of postsynaptic density 95 and inotropic glutamatergic receptor subunit in the mesocorticolimbic system of rat offspring born to Morphine-Addicted mothers. Biomed Res Int2018;
2018:5437092
37.
YangSNLiuCAChungMYHuangHCYehGCWongCSLinWWYangCHTaoPL.Alterations of postsynaptic density proteins in the hippocampus of rat offspring from the morphine-addicted mother: beneficial effect of dextromethorphan. Hippocampus2006;
16:521–30
38.
GoldbergLRGouldTJ.Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function. Eur J Neurosci2018;
39.
HulseGKMilneEEnglishDRHolmanCD.The relationship between maternal use of heroin and methadone and infant birth weight. Addiction (Abingdon, England)1997;
92:1571–9
40.
BashoreRAKetchumJSStaischKJBarrettCTZimmermannEG.Heroin addiction and pregnancy. West J Med1981;
134:506–14
41.
JonesHEMartinPRHeilSHKaltenbachKSelbyPCoyleMGStineSMO'GradyKEArriaAMFischerG.Treatment of opioid-dependent pregnant women: clinical and research issues. J Substance Abuse Treat2008;
35:245–59
42.
BinderTVavrinkovaB.Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett2008;
29:80–6
43.
PatrickSWDudleyJMartinPRHarrellFEWarrenMDHartmannKEElyEWGrijalvaCGCooperWO.Prescription opioid epidemic and infant outcomes. Pediatrics2015;
135:842–50
44.
HuntRWTzioumiDCollinsEJefferyHE.Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Human Dev2008;
84:29–35
45.
RosenTSJohnsonHL.Children of methadone-maintained mothers: follow-up to 18 months of age. J Pediatr1982;
101:192–6
46.
OstreaEMChavezCJ.Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J Pediatr1979;
94:292–5
47.
PaulJALoganBAKrishnanRHellerNAMorrisonDGPrithamUATisherPWTroeseMBrownMSHayesMJ.Development of auditory event-related potentials in infants prenatally exposed to methadone. Dev Psychobiol2014;
56:1119–28
48.
GuptaMMulvihillAOLascaratosGFleckBWGeorgeND.Nystagmus and reduced visual acuity secondary to drug exposure in utero: long-term follow-up. J Pediatr Ophthalmol Strabismus2012;
49:58–63
49.
GillACOeiJLewisNLYounanNKennedyILuiK.Strabismus in infants of opiate-dependent mothers. Acta Paediatrica2003;
92:379–85
50.
BunikowskiRGrimmerIHeiserAMetzeBSchaferAObladenM.Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr1998;
157:724–30
51.
GuoXSpencerJWSuessPEHickeyJEBetterWEHerningRI.Cognitive brain potential alterations in boys exposed to opiates: in utero and lifestyle comparisons. Addict Behav1994;
19:429–41
52.
OrnoyAMichailevskayaVLukashovIBar-HamburgerRHarelS.The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. Child Abuse Neglect1996;
20:385–96
53.
HickeyJESuessPENewlinDBSpurgeonLPorgesSW.Vagal tone regulation during sustained attention in boys exposed to opiates in utero. Addict Behav1995;
20:43–59
54.
OrnoyASegalJBar-HamburgerRGreenbaumC.Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol2001;
43:668–75
55.
BaldacchinoAArbuckleKPetrieDJMcCowanC.Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and Meta-analysis. BMC Psychiatry2014;
14:104
56.
GoetzlLThompson-FelixTDarbinianNMerabovaNMeraliSMeraliCSanserinoKTatevosianTFantBWimmerME.Novel biomarkers to assess in utero effects of maternal opioid use: first steps toward understanding short- and long-term neurodevelopmental sequelae. Genes Brain Behav2019;
18:e12583
57.
MartinCELonginakerNTerplanM.Recent trends in treatment admissions for prescription opioid abuse during pregnancy. J Substance Abuse Treat2015;
48:37–42
58.
PatrickSWDavisMMLehmannCUCooperWO.Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol2015;
35:650–5
59.
PatrickSWSchumacherREBenneyworthBDKransEEMcAllisterJMDavisMM.Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA2012;
307:1934–40
60.
HaightSCKoJYTongVTBohmMKCallaghanWM.Opioid use disorder documented at delivery hospitalization – United States, 1999–2014. MMWR Morb Mortal Wkly Rep2018;
67:845–9
61.
WinkelmanTNAVillapianoNKozhimannilKBDavisMMPatrickSW.Incidence and costs of neonatal abstinence syndrome among infants with medicaid: 2004–2014. Pediatrics2018;
141:pii:e20173520
62.
ToliaVNPatrickSWBennettMMMurthyKSousaJSmithPBClarkRHSpitzerAR.Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med2015;
372:2118–26
63.
LarsonJJGrahamDLSingerLTBeckwithAMTerplanMDavisJMMartinezJBadaHS.Cognitive and behavioral impact on children exposed to opioids during pregnancy. Pediatrics2019;
144:pii:e20190514
64.
ThompsonBLLevittPStanwoodGD.Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci2009;
10:303–12
65.
American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. 2017. p. Report 711
66.
ShonkoffJPLevittP.Neuroscience and the future of early childhood policy: moving from why to what and how. Neuron2010;
67:689–91
Veenstra-VanderWeeleJWarrenZ.Intervention in the context of development: pathways toward new treatments. Neuropsychopharmacology2015;
40:225–37
69.
ZwaigenbaumLBaumanMLChoueiriRKasariCCarterAGranpeeshehDMaillouxZSmith RoleySWagnerSFeinDPierceKBuieTDavisPANewschafferCRobinsDWetherbyAStoneWLYirmiyaNEstesAHansenRLMcPartlandJCNatowiczMR.Early intervention for children with autism spectrum disorder under 3 years of age: recommendations for practice and research. Pediatrics2015;
136: S60–81
70.
CioniGInguaggiatoESgandurraG.Early intervention in neurodevelopmental disorders: underlying neural mechanisms. Dev Med Child Neurol2016;
58: 61–6
71.
BadaHSBannCMWhitakerTMBauerCRShankaranSLagasseLLesterBMHammondJHigginsR.Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures. Pediatrics2012;
130:e1479–88
Davie-GrayAMoorSSpencerCWoodwardLJ.Psychosocial characteristics and poly-drug use of pregnant women enrolled in methadone maintenance treatment. Neurotoxicol Teratol2013;
38:46–52
74.
MolinaRLPaceLE.A renewed focus on maternal health in the United States. N Engl J Med2017;
377:1705–7
75.
KransEEPatrickSW.Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic. Obstet Gynecol2016;
128:4–10
76.
KoJYWolickiSBarfieldWDPatrickSWBroussardCSYonkersKANaimonRIskanderJ.CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome. MMWR Morb Mortal Wkly Rep2017;
66:242–5
77.
RobertsSCPiesC.Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care. Matern Child Health J2011;
15:333–41
78.
TerplanMMcNamaraEJChisolmMS.Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt. J Addict Dis2012;
31:342–9
79.
Bishop D, Borkowski L, Couillard M, Allina A, Baruch S, Wood S. Bridging the divide white paper: pregnant women and substance use: overview of research & policy in the United States 2017; https://hsrc.himmelfarb.gwu.edu/sphhs_centers_jacobs/5/ (accessed 11 October 2019)
